Cascades Capital Asset Management, LLC Milestone Pharmaceuticals Inc. Transaction History
Cascades Capital Asset Management, LLC
- $194 Billion
- Q2 2025
A detailed history of Cascades Capital Asset Management, LLC transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Cascades Capital Asset Management, LLC holds 67,135 shares of MIST stock, worth $137,626. This represents 0.07% of its overall portfolio holdings.
Number of Shares
67,135Holding current value
$137,626% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding MIST
# of Institutions
52Shares Held
16.8MCall Options Held
160KPut Options Held
34.8K-
Black Rock Inc. New York, NY4.97MShares$10.2 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$5.14 Million0.07% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.79MShares$3.67 Million4.22% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.4MShares$2.87 Million1.22% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$2.33 Million1.67% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $61.5M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...